| Per 0.1 increase in SHR | High vs. low SHR* |
---|---|---|
All-cause mortality | ||
Model 1 | 1.11 (1.04–1.19) | 1.63 (1.12–2.38) |
Model 2 | 1.12 (1.04–1.21) | 1.50 (1.01–2.23) |
Model 3 | 1.19 (1.11–1.28) | 1.97 (1.33–2.92) |
Model 4 | 1.18 (1.10–1.27) | 1.96 (1.32–2.92) |
Cardiovascular mortality or readmission for heart failure | ||
Model 1 | 1.17 (1.07–1.27) | 2.24 (1.32–3.79) |
Model 2 | 1.12 (1.02–1.22) | 1.79 (1.04–3.08) |
Model 3 | 1.26 (1.14–1.39) | 3.14 (1.76–5.59) |
Model 4 | 1.14 (1.05–1.25) | 2.51 (1.47–4.29) |
MACE | ||
Model 1 | 1.13 (1.02–1.24) | 1.76 (1.03–3.01) |
Model 2 | 1.12 (1.01–1.23) | 1.79 (1.03–3.12) |
Model 3 | 1.10 (1.00–1.21) | 1.85 (1.07–3.20) |
Model 4 | 1.15 (1.03–1.28) | 1.88 (1.08–3.27) |